Osteosarcopenisk obesity (OSO) syndrome, also defined as osteosarcopenisk adiposity (OSA), is characterized by the concurrent loss of bone and muscle mass alongside excess fat, resulting in reduced functionality and metabolic imbalances. Research indicates differential expression of microRNAs (miRNAs) in individuals with osteosarcopenia and obesity.
Study Methodology
A scoping review was conducted, examining 19 studies that met eligibility criteria following a comprehensive search of international bibliographic databases including Embase, PubMed, and Scopus. The search initially yielded 1311 records.
Key Findings and Future Directions
The review highlights the influence of physical exercise and nutritional factors on miRNA expression, emphasizing their potential role in promoting better health outcomes in aging populations. Animal studies have documented the critical role of miRNAs as indicators of muscle atrophy and the biological processes associated with aging and sarcopenia. These studies suggest that targeted interventions, such as resistance training and lifelong exercise, may effectively influence miRNA expression. Further investigation into these findings could lead to the development of biomarkers and therapeutic targets for managing OSO/OSA.